George E. Laramore, MD, PhDDr. Laramore treats patients for salivary gland tumors, head/neck cancer, sarcoma of soft tissue and bone at UW Medical Center.
Patient Care Philosophy:
High tech medicine can be adapted to the individual patient's needs. I enjoy using the latest technological innovations in radiation oncology to design and carry out the optimal treatment for each patient.
Dr. Laramore's Resume
- Professor, Radiation Oncology Department, University of Washington School of Medicine
- Radiation Oncologist, University of Washington Medical Center
- Radiation Oncologist, SCCA Proton Therapy, A ProCure Center
Salivary gland tumors, head and neck cancer, sarcoma of soft tissue and bone, fast neutron radiotherapy
Education And Training
- MD: University of Miami School of Medicine, 1976
- Residency: Radiation Oncology Radiation Oncology, University of Washington School of Medicine, 1977-1978
- Fellowship: American Cancer Society Clinical Fellow, 1979-1980
- Pre/Post-doctoral in physics: National Science Foundation, 1965-1970
- Dr. Laramore was recognized as a 2012 "Top Doctor" in Seattle Magazine's 2012 annual survey.
- Radiation Therapy vs. Androgen Deprivation
- Radiation w/wo Temozolomide for Low-Grade Gliomas (RTOG-1072)
- Whole Breast Irradiation with Hypofractionation versus standard Whole Breast Irradiation (RTOG 1005)
- Postoperative Radiation Therapy +/- Cetuximab for Head and Neck Cancer (RTOG 0920)
- Radiation Therapy + Chemotherapy for Stage T1 Bladder Cancer (UW 7684)
- Radiation Therapy With or Without Temozolomide for Anaplastic Glioma (RTOG 0834)
- Bevacizumab w/wo Radiation Therapy for Recurrent Glioblastoma (RTOG-1205)
- Registry Study for Proton Therapy Outcomes